Literature DB >> 26613601

Possible involvement of inflammatory/reparative processes in the development of uterine fibroids.

Olga Protic1, Paolo Toti2, Md Soriful Islam1,3, Rossella Occhini2, Stefano Raffaele Giannubilo4, William H Catherino5, Saverio Cinti1,6, Felice Petraglia7, Andrea Ciavattini4, Mario Castellucci8, Boris Hinz9, Pasquapina Ciarmela10,11.   

Abstract

Uterine leiomyomas are benign tumors in the smooth muscle layer of the uterus. The most common histological type is the "usual leiomyoma", characterized by overexpression of ECM proteins, whereas the "cellular type" has higher cellular content. Our objective is to investigate the involvement of inflammatory and reparative processes in leiomyoma pathobiology. Using a morphological approach, we investigate the presence of inflammatory cells. Next, we determine the localization of the ECM, the presence/absence of fibrotic cells via α-sma and desmin and the immunohistochemical profile of the mesenchymal cells with respect to CD34. Finally, we explore the effect of inflammatory mediators (TNF-α, IL-1β, IL-6, IL-15, GM-CSF and IFN-γ) on pro-fibrotic factor activin A mRNA expression in vitro. Higher numbers of macrophages were found inside and close to leiomyomas as compared to the more distant myometrium. Cellular leiomyomas showed more macrophages and mast cells than the "usual type". Inside the fibroid tissue, we found cells positive for α-sma, but negative for desmin and a large amount of collagen surrounding the nodule, suggestive of myofibroblasts producing ECM. In the myometrium and leiomyomas of the "usual type", we identified numerous CD34+ fibroblasts, which are known to give rise to myofibroblasts upon loss of CD34 expression. In leiomyomas of the "cellular type", stromal fibroblasts were CD34-negative. Finally, we found that TNF-α increased activin A mRNA in myometrial and leiomyoma cells. In conclusion, this study demonstrates the presence of inflammatory cells in uterine leiomyomas, which may contribute to excessive ECM production, tissue remodeling and leiomyoma growth.

Entities:  

Keywords:  Activin A; CD34; Cellular leiomyoma; ECM; Inflammation; Myofibroblast; Myometrium; TNF-α; Usual leiomyoma

Mesh:

Substances:

Year:  2015        PMID: 26613601     DOI: 10.1007/s00441-015-2324-3

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  38 in total

1.  The emerging spectrum of early life exposure-related inflammation and epigenetic therapy.

Authors:  Qiwei Yang; Mohamed Ali; Abdeljabar El Andaloussi; Ayman Al-Hendy
Journal:  Cancer Stud Mol Med       Date:  2018-09-17

2.  Inflammatory markers in women with reported benign gynecologic pathology: an analysis of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Lauren A King; Nicolas Wentzensen; Mark P Purdue; Hormuzd A Katki; Ligia A Pinto; Britton Trabert
Journal:  Ann Epidemiol       Date:  2021-12-11       Impact factor: 3.797

3.  Increased Expression of Fibroblast Activation Protein is Associated with Autophagy Dysregulation and Oxidative Stress in Obese Women with Uterine Fibroids.

Authors:  Nashwa Maghraby; Amira M El Noweihi; Nagla T El-Melegy; Nashwa A M Mostafa; Ahmed M Abbas; Heba E M El-Deek; Eman Radwan
Journal:  Reprod Sci       Date:  2021-11-29       Impact factor: 3.060

4.  Non-hormonal mediators of uterine fibroid growth.

Authors:  Esra Cetin; Ayman Al-Hendy; Michał Ciebiera
Journal:  Curr Opin Obstet Gynecol       Date:  2020-10       Impact factor: 1.927

5.  Uterine fibroids and risk of hypertension: Implication of inflammation and a possible role of the renin-angiotensin-aldosterone system.

Authors:  Decio Armanini; Chiara Sabbadin; Gabriella Donà; Luciana Bordin; Loris Marin; Alessandra Andrisani; Guido Ambrosini
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-22       Impact factor: 3.738

Review 6.  Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies†.

Authors:  Abdelrahman AlAshqar; Lauren Reschke; Gregory W Kirschen; Mostafa A Borahay
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

Review 7.  Macrophages and Immune Responses in Uterine Fibroids.

Authors:  Alessandro Zannotti; Stefania Greco; Pamela Pellegrino; Federica Giantomassi; Giovanni Delli Carpini; Gaia Goteri; Andrea Ciavattini; Pasquapina Ciarmela
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

8.  Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids.

Authors:  Md Soriful Islam; Sadia Afrin; Bhuchitra Singh; Friederike L Jayes; Joshua T Brennan; Mostafa A Borahay; Phyllis C Leppert; James H Segars
Journal:  Clin Transl Med       Date:  2021-07

9.  Tryptophan catabolism is dysregulated in leiomyomas.

Authors:  Tsai-Der Chuang; Derek Quintanilla; Drake Boos; Omid Khorram
Journal:  Fertil Steril       Date:  2021-06-09       Impact factor: 7.490

Review 10.  The Significance of Measuring Vitamin D Serum Levels in Women with Uterine Fibroids.

Authors:  Michał Ciebiera; Mohamed Ali; Lillian Prince; Stanisław Zgliczyński; Grzegorz Jakiel; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2020-10-27       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.